Canada· CA-DIN-02187116
SYNPHASIC 28 TABLETS
A norethisterone and ethinylestradiol product containing norethindrone + ethinyl estradiol, registered in Canada by PFIZER CANADA ULC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- NORETHINDRONE + ETHINYL ESTRADIOL
- Manufacturer
- PFIZER CANADA ULC
- Country
- Canada (CA)
- ATC code
- G03AB04
- ATC class
- Norethisterone and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
28 interactions on record for norethisterone and ethinylestradiol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Norethisterone and ethinylestradiol · interactions on record
28 records
28 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Norethisterone and ethinylestradiol in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAurovela 1.5/30Aurobindo Pharma Limited
- United KingdomBrevinor 500microgram/35microgram tabletsPfizer Ltd
- GermanyEve 20Gedeon Richter Plc.
- FinlandRapzidPfizer Oy
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Brevinor, Norimin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bdf3c37a-1fd5-4582-8d0d-4915898e434c GET /v1/drugs/bdf3c37a-1fd5-4582-8d0d-4915898e434c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02187116",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G03AB04",
"schedule": [
"Prescription"
],
"drug_code": "42890",
"strengths": [
"1.0 MG",
"0.5 MG",
"0.035 MG"
],
"ahfs_class": null,
"substances": [
"NORETHINDRONE",
"ETHINYL ESTRADIOL"
],
"product_categorization": null
}See everything about norethisterone and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.